Procyon Valuation
| PCYN Stock | USD 0.24 0.01 4.35% |
Procyon seems to be overvalued based on Macroaxis valuation methodology. Our model determines the value of Procyon from analyzing the company fundamentals such as Shares Outstanding of 8.09 M, operating margin of (0.07) %, and Return On Equity of -0.0934 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Procyon's price fluctuation is out of control at this time. Calculation of the real value of Procyon is based on 3 months time horizon. Increasing Procyon's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Procyon is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Procyon Pink Sheet. However, Procyon's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.24 | Real 0.2 | Hype 0.24 |
The intrinsic value of Procyon's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Procyon's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Procyon helps investors to forecast how Procyon pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Procyon more accurately as focusing exclusively on Procyon's fundamentals will not take into account other important factors: Procyon Total Value Analysis
Procyon is at this time anticipated to have valuation of 1.82 M with market capitalization of 2 M, debt of 694.3 K, and cash on hands of 1.04 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Procyon fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.82 M | 2 M | 694.3 K | 1.04 M |
Procyon Investor Information
About 65.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.77. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Procyon had not issued any dividends in recent years. Based on the analysis of Procyon's profitability, liquidity, and operating efficiency, Procyon is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.Procyon Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Procyon has an asset utilization ratio of 127.35 percent. This suggests that the Company is making $1.27 for each dollar of assets. An increasing asset utilization means that Procyon is more efficient with each dollar of assets it utilizes for everyday operations.Procyon Ownership Allocation
Procyon holds majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 65.0 pct. of Procyon outstanding shares that are owned by insiders implies they have been buying or selling the stock in recent months in anticipation of some upcoming event.Procyon Profitability Analysis
The company reported the previous year's revenue of 4.84 M. Net Loss for the year was (209.79 K) with profit before overhead, payroll, taxes, and interest of 3.49 M.About Procyon Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Procyon. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Procyon based exclusively on its fundamental and basic technical indicators. By analyzing Procyon's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Procyon's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Procyon. We calculate exposure to Procyon's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Procyon's related companies.Procyon Corporation, together with its subsidiaries, develops and markets proprietary medical products for use in the treatment of pressure ulcers, stasis ulcers, wounds, dermatitis, inflammation, and other skin problems in the United States. The company was incorporated in 1987 and is based in Oldsmar, Florida. Procyon Corp operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 19 people.
8 Steps to conduct Procyon's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Procyon's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Procyon's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Procyon's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Procyon's revenue streams: Identify Procyon's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Procyon's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Procyon's growth potential: Evaluate Procyon's management, business model, and growth potential.
- Determine Procyon's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Procyon's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Procyon Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 8.1 M | |
| Quarterly Earnings Growth Y O Y | -0.827 | |
| Retained Earnings | -1.9 M |
Other Information on Investing in Procyon Pink Sheet
Procyon financial ratios help investors to determine whether Procyon Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Procyon with respect to the benefits of owning Procyon security.